Effects of Ezetimibe Added to Ongoing Statin Therapy on C-Reactive Protein Levels in Hypercholesterolemic Patients

BACKGROUND AND OBJECTIVES: Ezetimibe alone does not decrease C-reactive protein (CRP) levels in hypercholesterolemic patients. However, several reports have suggested that ezetimibe might potentiate the effect of statin not only on cholesterol but also on CRP when administered together. We investiga...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Oh, Min Seok, Min, Yun Joo, Kwon, Jee Eun, Cho, Eun Jeong, Kim, Jung Eun, Lee, Wang-Soo, Lee, Kwang Je, Kim, Sang-Wook, Kim, Tae Ho, Kim, Chee Jeong, Ryu, Wang Seong
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Cardiology 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3116103/
https://ncbi.nlm.nih.gov/pubmed/21731566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2011.41.5.253
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky